Report : Organ Preservation Solutions Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Solution (University of Wisconsin Solution (UW), Custodiol HTK, Perfadex, and Others), Technique (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), and Organ Type (Kidneys, Liver, Lungs, Heart, and Others)
University of Wisconsin solution (UW) Segment Held Largest Share of Organ Preservation Solutions Market
According to our new research study on “Organ Preservation Solutions Market Forecast to 2028 - COVID-19 Impact and Analysis - by Solution, Technique, and Organ Type,” the market is projected to reach US$ 367,262.34 thousand by 2028 from US$ 235,566.90 thousand in 2021; it is expected to register a CAGR of 6.5% during 2021-2028. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.
Organ preservation solutions are used to protect organs prior to transplantation as they often collapse once removed from the human body. Organ preservation processes are employed for preserving organs for future applications such as transplantation and research. The growing global interest in organ transplantation procedures is likely to encourage developments in organ preservation techniques. In line with this, the development of mechanical techniques for would drive the demand for organ preservation solutions in the coming years
The organ preservation solutions market is characterized by the presence of various small and big companies. The market players are adopting the strategies such as new product launches, geographic expansions, and technological advancements to expand their market share. In September 2020, XVIVO Perfusion acquired Organ Assist, a Dutch MedTech company, and finances the acquisition through a private placement of new shares. Further, in June 2017, Essential Pharmaceuticals was acquired by Accord Healthcare. Under the terms of the agreement, Accord has acquired the rights to sell Custodiol HTK Solution of Essential Pharmaceuticals in the US and Canada.
Waters Medical Systems LLC; XVIVO Perfusion; TransMedics; OrganOx Limited; Paragonix Technologies, Inc.; Dr. Franz Koehler Chemie GmbH; Accord Healthcare; 21ST CENTURY MEDICINE; Shanghai Genext Pharmaceutical Technology,; and Bridge to Life Ltd are among the leading companies operating in the organ preservation solutions market.
On the basis of solution, the organ preservation solutions market is segmented into University of Wisconsin, solution (UW), custodiol HTK, perfadex, and others. Based on organ type, the market is segmented into kidneys, liver, lungs, heart, and others. By technique, the market is categorized into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. In terms of geography, the organ preservation solutions market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM).